Flexion Therapeutics, Inc. Repayments of Notes Payable
Flexion Therapeutics, Inc. reported Repayments of Notes Payable of $56.88 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfNotesPayable · last filed 2021-11-12
- Flexion Therapeutics, Inc. repayments of notes payable for the quarter ending 2021-09-30 was $49.24M.
- Flexion Therapeutics, Inc. repayments of notes payable for the quarter ending 2021-06-30 was $4.58M.
- Flexion Therapeutics, Inc. repayments of notes payable for the quarter ending 2021-03-31 was $3.06M.
- Flexion Therapeutics, Inc. repayments of notes payable for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Flexion Therapeutics, Inc. repayments of notes payable for fiscal 2019 was $14.37M, a 43.67% increase from fiscal 2018.
- Flexion Therapeutics, Inc. repayments of notes payable for fiscal 2018 was $10.00M.
- Flexion Therapeutics, Inc. repayments of notes payable for fiscal 2015 was $3.50M.
| Period end | Repayments of Notes Payable 3 month | Repayments of Notes Payable 6 month | Repayments of Notes Payable 9 month | Repayments of Notes Payable 12 month |
|---|---|---|---|---|
| 2021-09-30 | $49.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $53.82M derived: sum of 2 quarters · filed 2021-11-12 | $56.88M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $4.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $7.64M 10-Q · filed 2021-08-04 | ||
| 2021-03-31 | $3.06M 10-Q · filed 2021-05-12 | |||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-04 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $9.37M derived: sum of 2 quarters · filed 2021-03-10 | $11.87M derived: sum of 3 quarters · filed 2021-03-10 | $14.37M 10-K · filed 2021-03-10 |
| 2019-09-30 | $9.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $11.87M derived: sum of 2 quarters · filed 2020-11-04 | $14.37M 10-Q · filed 2020-11-04 | $16.87M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $5.00M 10-Q · filed 2020-08-05 | $7.50M derived: sum of 3 quarters · filed 2021-03-10 | $10.00M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | $2.50M 10-Q · filed 2020-05-07 | $5.00M derived: sum of 2 quarters · filed 2021-03-10 | $7.50M derived: sum of 3 quarters · filed 2021-03-10 | $10.00M derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $5.00M derived: sum of 2 quarters · filed 2021-03-10 | $7.50M derived: sum of 3 quarters · filed 2021-03-10 | $10.00M 10-K · filed 2021-03-10 |
| 2018-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $5.00M derived: sum of 2 quarters · filed 2019-11-07 | $7.50M 10-Q · filed 2019-11-07 | $10.00M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $5.00M 10-Q · filed 2019-08-06 | $7.50M derived: sum of 3 quarters · filed 2020-05-20 | $10.00M derived: sum of 4 quarters · filed 2020-05-20 |
| 2018-03-31 | $2.50M 10-Q · filed 2019-05-08 | $5.00M derived: sum of 2 quarters · filed 2020-05-20 | $7.50M derived: sum of 3 quarters · filed 2020-05-20 | $10.00M derived: sum of 4 quarters · filed 2020-05-20 |
| 2017-12-31 | $2.50M derived: 8-K 12 month − 10-Q 9 month · filed 2020-05-20 | $5.00M derived: sum of 2 quarters · filed 2020-05-20 | $7.50M derived: sum of 3 quarters · filed 2020-05-20 | $8.33M 8-K · filed 2020-05-20 |
| 2017-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $5.00M derived: sum of 2 quarters · filed 2018-11-07 | $5.83M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $3.33M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $833.00K 10-Q · filed 2018-05-08 | |||
| 2015-12-31 | $3.50M 10-K · filed 2018-03-08 |